Low-molecular weight human interleukin-1β antagonist discovered

Researchers described the detection of a human interleukin-1β antagonist with low molecular weight that disrupts interactions with the interleukin-1 receptor type I receptor.

Flagship launches first UK-based startup to uncover genes that make cells vulnerable or resistant to disease

A new biotech startup believes that genetic diversity found among the trillions of cells that comprise an individual person could hold the keys to new

November 22, 2023

Novavax’s Updated COVID Shot Authorized by FDA

The FDA authorized the updated Novavax COVID-19 vaccine to protect against hospitalization and death from circulating variants, the agency announced on Tuesday. Targeting the XBB.1.5

October 4, 2023

XOMA to buy Kinnate; A pain biotech’s small IPO

Plus, news about Blueprint Medicines, Sosei Group and Poxel: XOMA to buy Kinnate Biopharma: The biotech royalty aggregator said it would pay $2.33 per share

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.